Dr. Lamothe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1364 Clifton Rd NE
Atlanta, GA 30322Phone+1 404-712-2970
Education & Training
- Emory University School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2020 - 2023
- Emory University School of MedicineResidency, Internal Medicine, 2017 - 2020
- Harvard UniversityPhD, Biological Sciences in Public Health, 2012 - 2017
- Johns Hopkins UniversityMS, Biotechnology, 2008 - 2010
- Universidad La Salle School of MedicineClass of 2008
- Instituto Tecnologico y de Estudios Superiores de MonterreyBS, Electronic Systems Engineering, 1996 - 2000
Certifications & Licensure
- GA State Medical License 2021 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- Reply.Pedro A Lamothe, Martin C Runnstrom, F Eun-Hyung Lee
The Journal of Allergy and Clinical Immunology. 2024-11-08 - 1 citationsSARS-CoV-2-specific plasma cells are not durably established in the bone marrow long-lived compartment after mRNA vaccination.Doan C Nguyen, Ian T Hentenaar, Andrea Morrison-Porter, David Solano, Natalie S Haddad
Nature Medicine. 2024-09-27 - 4 citationsPatients taking benralizumab, dupilumab, or mepolizumab have lower postvaccination SARS-CoV-2 immunity.Martin C Runnstrom, Pedro A Lamothe, Caterina E Faliti, Narayanaiah Cheedarla, Alberto Moreno
The Journal of Allergy and Clinical Immunology. 2024-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: